The role of dendritic cells in neurodegenerative diseases

Archivum Immunologiae et Therapiae Experimentalis

Volumn 50, Issue 3, 2002, Pages 187-196

  Iribarren, Pablo ^a   Cui, You Hong ^a   Le, Yingying ^a   Wang, Ji Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CNS; Dendritic cells; Neurodegenerative diseases

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; ANIMAL; ANTIGEN PRESENTING CELL; BRAIN; DEGENERATIVE DISEASE; DENDRITIC CELL; HUMAN; IMMUNOLOGY; MICROGLIA; MULTIPLE SCLEROSIS; PHYSIOLOGY; PRION DISEASE; REVIEW;

ALZHEIMER DISEASE; ANIMALS; ANTIGEN-PRESENTING CELLS; BRAIN; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MICROGLIA; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; PRION DISEASES;

EID: 0036049245     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. ALOISI F., RIA F. and ADORINI L. (2000): Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol. Today, 21, 141-147.
2. ALUN BROWN K. (2001): Factors modifying the migration of lymphocytes across the blood-brain barrier. Int. Immunopharniacol., 1, 2043-2062.
3. AMAT J. A, ISHIGURO H., NAKAMURA K. and NORTON W. T. (1996): Phenotypic diversity and kinetics of proliferating microglia and astrocytes following cortical stab wounds. Glia, 16, 368-382.
4. AUCOUTURIER P., GEISSMANN F., DAMOTTE D., SABORIO G. P., MEEKER H. C., KASCSAK R., KASCSAK R., CARP R. I. and WisNIEWSKI T. (2001): Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J. Clin. Invest., 108, 703-708.
5. BANCHEREAU J. and STEINMAN R. M. (1998): Dendritic cells and the control of immunity. Nature, 392, 245-252.
6. BARD F., CANNON C., BARBOUR R., BURKE R. L., GAMES D., GRAJEDA H., GUIDO T., HU K., HUANG J., JOHNSON-WOOD K., KHAN K., KHOLODENKO D., LEE M., LIEBERBURG I., MOTTER R., NGUYEN M., SORIANO F., VASQUEZ N., WEISS K., WELCH B., SEUBERT P., SCHENK D. and YEDNOCK T. (2000): Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzhtimer disease. Nat. Med., 6, 916-919.
7. BECHER B. and ANTEL J. P. (1996): Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia, 18, 1-10.
8. BEEKES M. and MCBRIDE P. A. (2000): Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci. Lett., 278, 181-184.
9. BOTTO M., DELL'AGNOLA C., BYGRAVE A. E., THOMPSON E. M., COOK H. T., PETRY F., LOOS M., PANDOLFI P. P. and WALPORT M. J. (1998): Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet., 19, 56-59.
10. BRENAN M. and REES D. J. (1997): Sequence analysis of rat integrin alpha E1 and alpha E2 subunits: tissue expression reveals phenotypic similarities between intraepithelial lymphocytes and dendritic cells in lymph. Eur. J. Immunol., 27, 3070-3079.
11. BROWN D. R. and KRETZSCHMAR H. A. (1997): Microglia and prion disease: a review. Histol. Histopathol., 12, 883-892.
12. BROWN K. L, STEWART K., RITCHIE D. L., MABBOTT N. A., WILLIAMS A., FRASER H., MORRISON W. I. and BRUCE M. E. (1999): Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat. Med., 5, 1308-1312.
13. BUELER H., FISCHER M., LANG Y., BLUETHMANN H., LIPP H. P., DEARMOND S. J., PRUSINER S. B , AGUET M. and WEISSMANN C. (1992): Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature, 356, 577-582.
14. BURTHEM J., URBAN B., PAIN A. and ROBERTS D. J. (2001): The normal cellular prion protein is strongly expressed by myeloid dendritic cells. Blood, 98, 3733-3738.
15. CAUX C., MASSACRIER C., VANEERVLIET B., DUBOIS B., VAN KOOTEN C., DURAND I. and BANCHEREAU J. (1994): Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med., 180, 1263-1272.
16. CELLA M., SALIO M., SAKAKIBARA Y., LANGEN H., JULKUNEN I. and LANZAVECCHIA A. (1999): Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med., 189, 821-829.
17. CHAO C. C., HU S., PETERSON P. K. (1996): Glia: the not so innocent bystanders. J. Neurovirol., 2, 234-239.
18. CHAO C. C., HU S., SHENG W. S., BU D., BUKRINSKY M. I. and PETERSON P. K. (1996): Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia, 16, 276-284.
19. CUI Y. H., LE Y., GONG W., PROOST P., VAN DAMME J., MURPHY W. and WANG J. M. (2002): Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor FPR2 in murine microglial cells. J. Immunol., 168, 434-442.
20. DELGADO E., FINKEL V., BAGGIOLINI M., MACKAY C. R., STEINMAN R. M. and GRANELLI-PIPERNO A. (1998): Mature dendritic cells respond to SDF-1, but not to several beta-chemokines. Immunobiology, 198, 490-500.
21. DEL RIO HORTEGA P. (1932): Microglia. In: PENFIELD W.: Cytology and cellular pathology of the nervous system. Paul Hoeber, New York, 2, 481-534.
22. DE SIMONE R., GIAMPAOLO A., GIOMETTO B., GALLO P., LEVI G., PESCHLE C. and ALOISI F. (1995): The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol., 54, 175-187.
23. DIEU M. C., VANBERVLIET B., VICARI A., BRIDON J. M., OLDHAM E., AIT-YAHIA S., BRIERE F., ZLOTNIK A., LEBECQUE S. and CAUX C. (1998): Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med., 188, 373-386.
24. DITTEL B. N., VISINTIN I., MERCHANT R. M and JANEWAY C. A. JR. (1999): Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol., 163, 32-39.
25. FEARNLEY D. B., WHYTE L. F., CARNOUTSOS S. A., COOK A. H., HART D. N. (1999): Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood, 93, 728-736.
26. FEDOROFF S., ZHAI R. and NOVAK J. P. (1997): Microglia and astroglia have a common progenitor cell. J. Neurosci. Res., 50, 477-486.
27. FINKELMAN F. D., LEES A., BIRNBAUM R., GAUSE W. C. and MORRIS S. C. (1996): Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol., 157, 1406-1414.
28. FISCHER H. G., BONIFAS U. and REICHMANN G. (2000): Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J. Immunol., 164, 4826-4834.
29. FISCHER H. G. and REICHMANN G. (2001): Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol., 166, 2717-2726.
30. FLARIS N. A., DENSMORE T. L., MOLLESTON M. C. and HICKEY W. F. (1993): Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia, 7, 34-40.
31. GIULIAN D., CHEN J., INGEMAN J. E., GEORGE J. K. and NOPONEN M. (1989): The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J. Neurosci., 9, 4416-4429.
32. GIULIAN D., WOODWARD J., YOUNG D. G., KREBS J. F. and LACHMAN L. B. (1988): Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci., 8, 2485-2490.
33. GONZALEZ-SCARANO F. and BALTUCH G. (1999): Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci., 22, 219-240.
34. GRAEBER M. B., STREIT W. J., BURINGER D., SPARKS D. L. and KREUTZBERG G. W. (1992): Ultrastructural location of major histocompatibility complex (MHC) class II perivascular cells in histologically normal human brain. J. Neuropathol. Exp. Neurol., 51, 303-311.
35. GRAEBER M. B., STREIT W. J., KREUTZBERG G. W. (1988): Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J. Neurosci. Res., 21, 18-24.
36. GUNN M. D., KYUWA S., TAM C., KAKIUCHI T., MATSUZAWA A., WILLIAMS L. T. and NAKANO H. (1999): Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med., 189, 451-460.
37. HAINFELLNER J. A. and BUDKA H. (1999): Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies. Acta Neuropathol., 98, 458-460.
38. HART D. N. (1997): Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 90, 3245-3287.
39. HARTMANN G., WEINER G. J. and KRIEG A. M. (1999): CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA, 96, 9305-9310.
40. HEUFLER C., KOCH F. and SCHULER G. (1988): Granulocyte/ /macrophage colony-stimulating factor and interleukin-1-mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med., 167, 700-705.
41. HILL A. F., BUTTERWORTH R. J., JOINER S., JACKSON G., ROSSOR M. N., THOMAS D. J., FROSH A., TOLLEY N., BELL J. E., SPENCER M., KING A., AL-SARRAJ S., IRONSIDE J. W., LANTOS P. L. and COLLINGE J. (1999): Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet, 353, 183-189.
42. INABA K., INABA M., NAITO M. and STEINMAN R. M. (1993): Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med., 178, 479-488.
43. JIANG W., SWIGGARD W. J., HEUFLER C., PENG M., MIRZA A., STEINMAN R. M. and NUSSENZWEIG M. C. (1995): The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature, 375, 151-155.
44. KALTSCHMIDT C., KALTSCHMIDT B., LANNES-VIEIRA J., KREUTZBERG G. W., WEKERLE H., BAEUERLE P. A. and GEHRMANN J. (1994): Transcription factor NF-κ B is activated in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol., 55, 99-106.
45. KAPASI Z. F., BURTON G. F., SHULTZ L. D., TEW J. G. and SZAKAL A. K. (1993): Induction of functional follicular dendritic cell development in severe combined immunodeficiency mice. Influence of B and T cells. J. Immunol., 150, 2648-2658.
46. KIMBERLIN R. H. and WALKER C. A. (1979): Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol., 89, 551-562.
47. KLEIN M. A., KAESER P. S., SCHWARZ P., WEYD H., XENARIOS I., ZINKERNAGEL R. M., CARROLL M. C., VERBEEK J. S., BOTTO M., WALPORT M. J., MOLINA H., KALINKE U., ACHA-ORBEA H. and AGUZZI A. (2001): Complement facilitates early prion pathogenesis. Nat. Med., 7, 488-492.
48. LABEUR M. S., ROTERS B., PERS B., MEHLING A., LUGER T. A., SCHWARZ T. and GRABBE S. (1999): Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol., 162, 168-175.
49. LANZAVECCHIA A. and SALLUSTO F. (2001): The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol., 13, 291-298.
50. LASSMANN H., SCHMIED M., VASS K., HICKEY W. F. (1993): Bone marrow derived elements and microglia in brain inflammation. Glia, 7, 19-24.
51. LAWSON L. J., PERRY V. H., DRI P. and GORDON S. (1990): Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience, 39, 151-170.
52. LE Y., OPPENHEIM J. J. and WANG J. M. (2001): Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev., 12, 91-105.
53. LE Y., YAZAWA H., GONG W., YU Z., FERRANS V. J., MURPHY P. M. and WANG J. M. (2001): The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol., 166, 1448-1451.
54. LINK H., HUANG Y. M., MASTERMAN T and XIAO B. G. (2001): Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis. J. Neuroimmunol., 114, 1-7.
55. MABBOTT N. A., BRUCE M. E., BOTTO M., WALPORT M. J. and PEPYS M. B. (2001): Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat. Med., 7, 485-487.
56. MABBOTT N. A., WILLIAMS A., FARQUHAR C. F., PASPARAKIS M., KOLLIAS G. and BRUCE M. E. (2000): Tumor necrosis factor α-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J. Virol., 74, 3338-3344.
57. MANSON J. C., CLARKE A. R., HOOPER M. L., AITCHISON L., MCCONNELL I. and HOPE J. (1994): 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol., 8, 121-127.
58. MATYSZAK M. K. and PERRY V. H. (1996): The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience, 74, 599-608.
59. MCGEER E. G. and MCGEER P. L. (1998): The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol., 33, 371-378.
60. NUNAN J. and SMALL D. H. (2000): Regulation of APP cleavage by α-, β-and γ-secretases. FEBS Lett., 483, 6-10.
61. PERRY V. H. (1994): Macrophages and the nervous system. Landes R. G. Company, Austin, 6-27.
62. PERRY V. H., BOLTON S. J., ANTHONY D. C., and BETMOUNI S. (1998): The contribution of inflammation to acute and chronic neurodegeneration. Res. Immunol., 149, 721-725.
63. PRUSINER S. B. (1998): Prions. Proc. Natl. Acad. Sci. USA, 95, 13363-13383.
64. RAINE C. S. (1994): The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol., 36, 61-72.
65. RAINE C. S. and CANNELLA B. (1992): Adhesion molecules and central nervous system inflammation. Semin. Neurosci., 4, 201-211.
66. REESE T. S. and KARNOVSKY M. J. (1967): Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell. Biol., 34, 207-217.
67. REID D. M., PERRY V. H., ANDERSSON P. B and GORDON S. (1993): Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier. Neuroscience, 56, 529-533.
68. RESCIGNO M., GRANUCCI F., CITTERIO S., FOTI M., and RICCIARDI-CASTAGNOLI P. (1999): Coordinated events during bacteria-induced DC maturation. Immunol. Today, 20, 200-203.
69. ROAKE J. A., RAO A. S., MORRIS P. J., LARSEN C. P., HANKINS D. F., AUSTYN J. M. (1995): Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med., 181, 2237-2247.
70. SALLUSTO F., CELLA M., DANIELI C. and LANZAVECCHIA A. (1995): Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med., 182, 389-400.
71. SALLUSTO F. and LANZAVECCHIA A. (1994): Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med., 179, 1109-1118.
72. SALLUSTO F. and LANZAVECCHIA A. (1995): Dendritic cells use macropinocytosis and the mannose receptor to concentrate antigen to the MHC class II compartment. Downregulation by cytokines and bacterial products. J. Exp. Med., 182, 389-400.
73. SALLUSTO F. and LANZAVECCHIA A. (2000): Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev., 177, 134-140.
74. SALLUSTO F., PALERMO B., LENIG D., MIETTINEN M., MATIKAINEN S., JULKUNEN I., FORSTER R., BURGSTAHLER R., LIPP M. and LANZAVECCHIA A. (1999): Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol., 29, 1617-1625.
75. SANTAMBROGIO L., BELYANSKAYA S. L., FISCHER F. R., CIPRIANI B., BROSNAN C. F., RICCIARDI-CASTAGNOLI P., STERN L. J., STROMINGER J. L. and RIESE R. (2001): Developmental plasticity of CNS microglia. Proc. Natl. Acad. Sci. USA, 98, 6295-6300.
76. SCHMITT T. L., STEGER M. M., PAVELKA M. and GRUBECK-LOEBENSTEIN B. (1997): Interactions of the Alzheimer beta amyloid fragment (25-35) with peripheral blood dendritic cells. Mech. Ageing Dev., 94, 223-232.
77. SMALL D. H. and MCLEAN C. A. (1999): Alzheimer's disease and the amyloid beta protein: What is the role of amyloid? J. Neurochem., 73, 443-449.
78. SOZZANI S., ALLAVENA P., D'AMICO G., LUINI W., BIANCHI G., KATAURA M., IMAI T., YOSHIE O., BONECCHI R. and MANTOVANI A. (1998): Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol., 161, 1083-1086.
79. SOZZANI S., SALLUSTO F., LUINI W., ZHOU D., PIEMONTI L., ALLAVENA P., VAN DAMME J., VALITUTTI S., LANZAVECCHIA A. and MANTOVANI A. (1995): Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol., 155, 3292-3295.
80. SPRENT J. (1995): Antigen-presenting cells. Professionals and amateurs. Curr. Biol., 5, 1095-1097.
81. STEINMAN L. (1996): Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell, 85, 299-302.
82. TAYLOR P. R., NASH J. T., THEODORIDIS E., BYGRAVE A. E., WALPORT M. J. and BOTTO M. (1998): A targeted disruption of the murine complement factor U gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J. Biol. Chem., 273, 1699-1704.
83. TEW J. G., WU J., FAKHER M., SZAKAL A. K. and QIN D. (2001): Follicular dendritic cells beyond the necessity of T-cell help. Trends Immunol., 22, 361-367.
84. ULVESTAD E., WILLIAMS K., BJERKVIG R., TIEKOTTER K., ANTEL J. and MATRE R. (1994): Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J. Leukoc. Biol., 56, 732-740.
85. VAN KEULEN L. J., SCHREUDER B. E., MELOEN R. H., MOOIJ-HARKES G., VROMANS M. E. and LANGEVELD J. P. (1996): Immunohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapie. J. Clin. Microbiol., 34, 1228-1231.
86. WELLER R. O. (1998): Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J. Neuropathol. Exp. Neurol., 57, 885-894.
87. WENINGER S. C. and YANKNER B. A. (2001): Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat. Med., 7, 527-528.
88. + T cells. J. Neuroimmunol., 97, 25-36.
89. XIAO B. G., HUANG Y. M., YANG J. S., XU L. Y. and LINK H. (2001): Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats. Clin. Exp. Immunol., 125, 300-309.
90. YANG D., CHEN Q., LE Y., WANG J. M. and OPPENHEIM J. J. (2001): Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J. Immunol., 166, 4092-4098.
91. YANG D., HOWARD O. M., CHEN Q. and OPPENHEIM J. J. (1999): Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-β1 express functional C-C chemokine receptor 6. J. Immunol., 163, 1737-1741.
92. YANKNER B. A. (1996): Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron., 16, 921-932.